ACT Capital Management’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-24,700
Closed -$791K 129
2021
Q2
$791K Buy
+24,700
New +$791K 0.41% 45